Biocept Inc develops and commercializes molecular diagnostic assays that provide physicians with clinically actionable information for treating and monitoring patients diagnosed with a variety of cancers.
Ratings
0 / 5
0 ratings in the last 12 months
5
4
3
2
1
CEO
Mr. Samuel D. Riccitelli$1.3M
Market Cap • 23/10/20231997
(há 27 anos)
2014
(10 years ago)
NASDAQ
Listagem
San Diego
Sede • California50
N° de Empregados • 2022Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
BIOCSó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.